Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to -$67251.0.

  • cbdMD's Change in Accured Expenses rose 9572.69% to -$67251.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$261883.0, marking a year-over-year increase of 7670.37%. This contributed to the annual value of -$261883.0 for FY2025, which is 7670.37% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's Change in Accured Expenses is -$67251.0, which was up 9572.69% from $82503.0 recorded in Q2 2025.
  • cbdMD's 5-year Change in Accured Expenses high stood at $763157.0 for Q2 2021, and its period low was -$1.6 million during Q3 2024.
  • Its 5-year average for Change in Accured Expenses is -$162756.8, with a median of -$40365.0 in 2025.
  • As far as peak fluctuations go, cbdMD's Change in Accured Expenses tumbled by 149492.94% in 2023, and later surged by 2057744.36% in 2025.
  • Over the past 5 years, cbdMD's Change in Accured Expenses (Quarter) stood at -$127254.0 in 2021, then soared by 130.81% to $39204.0 in 2022, then surged by 262.95% to $142292.0 in 2023, then plummeted by 266.4% to -$236770.0 in 2024, then soared by 71.6% to -$67251.0 in 2025.
  • Its Change in Accured Expenses was -$67251.0 in Q3 2025, compared to $82503.0 in Q2 2025 and -$40365.0 in Q1 2025.